Human iPS-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anti-Cancer Efficacy and Cardiotoxicity.

Cancer remains a leading health threat in the United States, and cardiovascular drug toxicity is a primary cause to eliminate a drug from FDA approval. As a result, the demand to develop new antica...